9/5/07

Frontage acquires new location in Exton | 8:00 AM. Frontage announces the acquisition of an additional 25,000 sq.ft. operations space in Exton, PA. The new facility will include GMP manufacturing capabilities for oral solid dose, liquid and sterile products and clinical trial materials. The new site will be home to the GMP Pharmaceutical Analysis and Formulation Development groups. The new facility will also allow Frontage to create 30-40 new employment opportunities for the state of Pennsylvania. Please contact Ron Connolly, 610-232-0100 for more information.

6/15/07

Frontage Laboratories acquires stake in ABR | 8:00 AM. MALVERN, PA June 15, 2007/PRNewswire/ -- Frontage Laboratories, a leading high quality provider of bioanalytical, pre-clinical and drug development services to the pharmaceutical industry, announced today it has acquired a significant equity interest in Advanced Biomedical Research, Inc. (ABR) (http://www.abr-pharma.com), an international, full service CRO. the combined resources of Frontage and ABR offer unparalleled formulation development, bioanalytical and GMP testing services, Phase I-II study performance in a state-of-the-art 72-bed clinical research facility, and “turn key” multinational Phase II-IV CRO services.